Video
Dr. John Valvo on who should receive HIFU
Author(s):
“You can't just have all or none treatments. You've got to have a middle ground for people who are going to look for that,” says John R. Valvo, MD.
Video Player is loading.
In this video, John R. Valvo, MD, discusses an example of a potential candidate for high-intensity focused ultrasound treatment. Valvo is Director of Robotics at Rochester Regional Health in Rochester, New York, a clinical associate professor and Chief of Urology for Via Health in Rochester, and Executive Director of the Polissini Center for Robotic and Minimally Invasive Surgery at Rochester General Hospital.
Related Videos
Study results show CVAC 2.0 is safe, efficacious for wide range of kidney stones
De novo metastatic prostate cancer: Understanding Biden’s prognosis and treatment
Geoffrey Sonn, MD, on an AI risk mapping tool to predict seminal vesicle invasion
Alternative treatments and patient communication for genitourinary syndrome of menopause
Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsy
Prostate cancer screening: Expert weighs in after Biden's diagnosis
Sarah Razavi, MD, discusses the physical toll of ureteroscopy on urologists
Clinical Outcomes of Ultra-Low PSA Responses in Patients With mHSPC Receiving Darolutamide Plus ADT
Post Hoc Analysis of ARANOTE; Ultra-Low PSA Responses
Study results affirm effectiveness of evolving prostate cancer therapies
Related Content
